Source: GlobalData
Contactless vital monitoring to transform digital healthcare, says GlobalData
Posted in Medical Devices
PanopticAI has revolutionized patient monitoring by developing the world’s first FDA-cleared app for contactless pulse rate measurement. Using remote photoplethysmography (rPPG) algorithms and smartphone cameras, this innovation eliminates the need for costly medical equipment, making healthcare more accessible and scalable, says GlobalData, a leading data and analytics company.
With just a 30-second scan, the app provides accurate vital sign readings, transforming everyday smartphones into a medical-grade tool. This development marks a major milestone in the shift toward AI-driven, consumer-focused digital health solutions that empower patients and expand global healthcare access.
Elia Garcia, Medical Analyst at GlobalData, comments: “Beyond its technological innovation, PanopticAI’s FDA recent clearance highlights the importance of Software as a Medical Device (SaMD) within healthcare systems. The app was validated through rigorous testing across diverse patient demographics and environmental conditions, ensuring it works reliably in real-world scenarios. Its adoption by hospitals, insurers, and pharmacies—such as Gleneagles Hospital and Bupa—illustrates the growing demand for accessible, preventive care solutions.”
PanopticAI exemplifies how digital health can bridge gaps in traditional healthcare by simplifying monitoring and reducing costs, especially in underserved populations or regions with limited healthcare resources.
Garcia concludes: “PanopticAI’s breakthrough aligns with key trends, including the increasing consumerization of healthcare, the proliferation of AI-powered solutions, and the shift toward preventive care. Leveraging everyday devices such as smartphones reduces dependency on expensive wearables, breaking barriers to adoption.”